| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.091 | 0.06 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.079 | 0.07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.078 | 0.08 |